Literature DB >> 20572039

Relation between normal rectal methylation, smoking status, and the presence or absence of colorectal adenomas.

Bogdan C Paun1, Debra Kukuruga, Zhe Jin, Yuriko Mori, Yulan Cheng, Mark Duncan, Sanford A Stass, Elizabeth Montgomery, David Hutcheon, Stephen J Meltzer.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is 1 of the leading causes of death in the Western world. CRC develops from premalignant lesions, chiefly colorectal adenomas. Currently, the most accurate and recommended screening method for finding colorectal adenomas is colonoscopy performed on all individuals aged>50 years. However, the costs and risks associated with this procedure are relatively high. The objectives of the current study were to correlate epigenetic alterations that occur in normal rectal mucosa, smoking status, and age with the presence or absence of concomitant colorectal adenomas and to assess the potential clinical value of methylation in normal rectal biopsies as a screening assay for the presence of polyps and, hence, the need for a full colonoscopy.
METHODS: One hundred thirteen normal rectal mucosal biopsies from 113 patients were studied. DNA was extracted, modified with sodium bisulfite, and subjected to real-time quantitative, methylation-specific polymerase chain reaction analysis for the following genes: adenomatous polyposis coli (APC); cadherin 1, type 1, E-cadherin (epithelial) (CDH1); estrogen receptor 1 (ESR1); cytokine high in normal 1 (HIN1); hyperplastic polyposis protein 1 (HPP1); O-6 methylguanine-DNA methyltransferase (MGMT); neural epidermal growth factor-like 1 (NELL1); splicing factor 3B, 14-kDa subunit (p14); cyclin-dependent kinase (CDK) inhibitor 2B (inhibits CDK4) (p15); retinoic acid receptor beta (RARβ); somatostatin (SST); tachykinin, precursor 1 (TAC1); and tissue inhibitor of metalloproteinase (TIMP) metallopeptidase inhibitor 3 (TIMP3). Data were then analyzed using several proprietary software programs.
RESULTS: By using several sets of genes, clinical characteristics, and multivariate analyses, the authors developed a prediction model for the presence of concomitant colorectal adenomas at the time of rectal biopsy. They also observed strong correlations between smoking status and rectal methylation pattern and between smoking status and the presence or risk of concomitant adenomas.
CONCLUSIONS: A prediction model was developed for the presence of colorectal adenomas based on gene methylation patterns in the normal rectum. The results indicated that these genes may be involved in early stages of adenoma formation. The observed epigenetic alterations in these markers may be caused in part by the effects of smoking and/or age. Normal rectal methylation may be useful as a biomarker for narrowing the population in need of screening colonoscopy.
Copyright © 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 20572039      PMCID: PMC2988654          DOI: 10.1002/cncr.25348

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  29 in total

1.  Aberrant methylation of gene promoters in cancer---concepts, misconcepts, and promise.

Authors:  S B Baylin; S A Belinsky; J G Herman
Journal:  J Natl Cancer Inst       Date:  2000-09-20       Impact factor: 13.506

Review 2.  Nutrition and colon cancer prevention.

Authors:  James R Marshall
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-09       Impact factor: 4.294

3.  Hypomethylation of DNA from benign and malignant human colon neoplasms.

Authors:  S E Goelz; B Vogelstein; S R Hamilton; A P Feinberg
Journal:  Science       Date:  1985-04-12       Impact factor: 47.728

4.  Hereditary proximal colonic cancer.

Authors:  P M Lynch; H T Lynch; R E Harris
Journal:  Dis Colon Rectum       Date:  1977 Nov-Dec       Impact factor: 4.585

Review 5.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

Review 6.  DNA methylation and gastrointestinal malignancies: functional consequences and clinical implications.

Authors:  M Toyota; F Itoh; K Imai
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

7.  Risk factors for colorectal cancer: an epidemiologic descriptive study of a series of 333 patients.

Authors:  Adina Neagoe; Ana-Maria Molnar; Monica Acalovschi; Andrada Seicean; Alexandru Serban
Journal:  Rom J Gastroenterol       Date:  2004-09

8.  Hypomethylation of ras oncogenes in primary human cancers.

Authors:  A P Feinberg; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1983-02-28       Impact factor: 3.575

9.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts.

Authors:  A P Feinberg; B Vogelstein
Journal:  Nature       Date:  1983-01-06       Impact factor: 49.962

10.  The relationship between hypomethylation and CpG island methylation in colorectal neoplasia.

Authors:  Carolyn Bariol; Catherine Suter; Kay Cheong; Su-Lyn Ku; Alan Meagher; Nicholas Hawkins; Robyn Ward
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

View more
  22 in total

1.  Somatostatin methylation as a biomarker for gastric cancer: ready for "prime time" or for further validation?

Authors:  Ajay Goel
Journal:  Dig Dis Sci       Date:  2011-01       Impact factor: 3.199

2.  Light-scattering technologies for field carcinogenesis detection: a modality for endoscopic prescreening.

Authors:  Vadim Backman; Hemant K Roy
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

3.  Colonic mucosal fatty acid synthase as an early biomarker for colorectal neoplasia: modulation by obesity and gender.

Authors:  Mart Dela Cruz; Ramesh K Wali; Laura K Bianchi; Andrew J Radosevich; Susan E Crawford; Lisa Jepeal; Michael J Goldberg; Jaclyn Weinstein; Navneet Momi; Priya Roy; Audrey H Calderwood; Vadim Backman; Hemant K Roy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-25       Impact factor: 4.254

4.  DNA demethylation in normal colon tissue predicts predisposition to multiple cancers.

Authors:  H Kamiyama; K Suzuki; T Maeda; K Koizumi; Y Miyaki; S Okada; Y J Kawamura; J K Samuelsson; S Alonso; F Konishi; M Perucho
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

5.  Neo-angiogenesis and the premalignant micro-circulatory augmentation of early colon carcinogenesis.

Authors:  Ashish K Tiwari; Susan E Crawford; Andrew Radosevich; Ramesh K Wali; Yolanda Stypula; Dhananjay P Kunte; Nikhil Mutyal; Sarah Ruderman; Andrew Gomes; Mona L Cornwell; Mart De La Cruz; Jeffrey Brasky; Tina P Gibson; Vadim Backman; Hemant K Roy
Journal:  Cancer Lett       Date:  2011-04-14       Impact factor: 8.679

Review 6.  The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening.

Authors:  William M Grady; Sanford D Markowitz
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

Review 7.  Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.

Authors:  Federica Zoratto; Luigi Rossi; Monica Verrico; Anselmo Papa; Enrico Basso; Angelo Zullo; Luigi Tomao; Adriana Romiti; Giuseppe Lo Russo; Silverio Tomao
Journal:  Tumour Biol       Date:  2014-03-28

8.  Patterns of DNA methylation in the normal colon vary by anatomical location, gender, and age.

Authors:  Andrew M Kaz; Chao-Jen Wong; Slavomir Dzieciatkowski; Yanxin Luo; Robert E Schoen; William M Grady
Journal:  Epigenetics       Date:  2014-01-10       Impact factor: 4.528

Review 9.  Field cancerisation in colorectal cancer: a new frontier or pastures past?

Authors:  Abhilasha Patel; Gyanendra Tripathi; Kishore Gopalakrishnan; Nigel Williams; Ramesh P Arasaradnam
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

10.  Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon.

Authors:  Devin C Koestler; Jing Li; John A Baron; Gregory J Tsongalis; Lynn F Butterly; Martha Goodrich; Corina Lesseur; Margaret R Karagas; Carmen J Marsit; Jason H Moore; Angeline S Andrew; Amitabh Srivastava
Journal:  Mod Pathol       Date:  2013-07-19       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.